<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="136174">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01909180</url>
  </required_header>
  <id_info>
    <org_study_id>106-2011-GES-0003</org_study_id>
    <nct_id>NCT01909180</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation for GE CT System</brief_title>
  <official_title>Clinical Evaluation for GE CT System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GE Healthcare</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An external evaluation to obtain clinical data to create sample clinical images.

      The data will also be used for product and technology development, marketing materials, and
      inclusion in publications.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <primary_completion_date type="Anticipated">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Image Quality</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Computed Tomography</condition>
  <arm_group>
    <arm_group_label>Standard of care scan</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This is a single arm clinical trial.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard of care scan</intervention_name>
    <arm_group_label>Standard of care scan</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Investigational Scan</intervention_name>
    <arm_group_label>Standard of care scan</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects who voluntarily signed the Informed Consent Form (ICF).

          -  Male subjects 18 years of age or older.

          -  Female subjects 18 years of age or older. Females between 18 and 60 years of age must
             be non-lactating and non-pregnant as confirmed by negative urine pregnancy test.,
             unless they had surgery resulting in sterilization or are post-menopausal according
             to the medical history.

        Exclusion Criteria:

          -  â€¢ Subjects previously enrolled in this Evaluation.

               -  Subjects who are not able or not willing to give written Informed Consent.

               -  For IV contrast-enhanced CT exams, anyone with known or suspected allergy to
                  iodinated contrast agents or a history of multiple allergies or asthma.

               -  For IV contrast-enhanced CT exams, per the institution's guidelines on risk
                  stratification and prophylaxis for Contrast Induced Neuropathy, subjects will be
                  pre-screened via medical history review by qualified medical personnel for
                  suspected renal function impairment and high risk subjects will undergo a serum
                  creatinine lab test. Any subject with proven renal insufficiency will be
                  excluded.

               -  Known pregnancy and nursing (lactating) females.

               -  Any subject with urgent medical condition requiring acute care.

               -  Any conditions that, in the opinion of the Investigator, would interfere with
                  the evaluation of the results or constitute a health hazard for the subject.

               -  Subjects who do not agree to allow GEHC personnel to be present during the scan.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mikhail Chkolnik, MD</last_name>
    <phone>262-548-2799</phone>
    <email>mikhail.chkolnik@ge.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Baptist South Florida Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 26, 2013</lastchanged_date>
  <firstreceived_date>July 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
